Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV ‐2 exposure
Cells of the innate immune system represent the first line of defense against SARS‐CoV‐2 and play an essential role in activating adaptive immunity, which mediates long‐term protection. In addition, the same cells are key drivers of tissue damage by causing the hyperinflammatory state and cytokine storm that makes COVID‐19 a deadly disease. Thus, careful dissection of the host–pathogen interaction on a cellular level is essential to understanding SARS‐CoV‐2 pathogenesis and developing new treatment modalities against COVID‐19. In their recent work, Goffinet and colleagues (Kazmierski et al, 2022) investigate the cell‐intrinsic responses of human primary peripheral blood mononuclear cells (PBMCs) exposed to SARS coronaviruses.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Monocyte‐crosstalk drives interferon‐mediated signaling following SARS‐CoV ‐2 exposure ; volume:18 ; number:9 ; year:2022 ; extent:2
Molecular systems biology ; 18, Heft 9 (2022) (gesamt 2)
- Urheber
-
Theobald, Sebastian J.
Rybniker, Jan
- DOI
-
10.15252/msb.202211256
- URN
-
urn:nbn:de:101:1-2022091215110890846051
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Theobald, Sebastian J.
- Rybniker, Jan
Ähnliche Objekte (12)
SARS-CoV-2 and interferon blockade
Macrophage and Monocyte Responses to SARS-CoV-2
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
Interferon antagonists encoded by SARS-CoV-2 at a glance
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection
Immune–epithelial cell cross‐talk enhances antiviral responsiveness to SARS‐CoV ‐2 in children
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
SARS-CoV-2 and interferon blockade
Macrophage and Monocyte Responses to SARS-CoV-2
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
Interferon antagonists encoded by SARS-CoV-2 at a glance
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection
Immune–epithelial cell cross‐talk enhances antiviral responsiveness to SARS‐CoV ‐2 in children
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections
Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
SARS-CoV-2 and interferon blockade
Macrophage and Monocyte Responses to SARS-CoV-2
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities
Interferon antagonists encoded by SARS-CoV-2 at a glance
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
Monocyte distribution width as a pragmatic screen for SARS-CoV-2 or influenza infection
Immune–epithelial cell cross‐talk enhances antiviral responsiveness to SARS‐CoV ‐2 in children
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment
Role of interferon gamma in SARS-CoV-2-positive patients with parasitic infections